SINGLE DOMAIN ANTIBODIES FOR PREVENTION OF CLOSTRIDIUM DIFFICILE INFECTION

The present disclosure relates to single domain antibodies which binds to Clostridium difficile toxin B and their use in the treatment and prevention of Clostridium difficile infection. Further disclosed are nucleic acids and vectors encoding the single domain antibodies, host cells for expression o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LAUSTSEN, Mads Aage, THRANE, Sandra Wingaard, LAUSTSEN, Andreas Hougaard, RODRIGUEZ-RODRIGUEZ, Everardo
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LAUSTSEN, Mads Aage
THRANE, Sandra Wingaard
LAUSTSEN, Andreas Hougaard
RODRIGUEZ-RODRIGUEZ, Everardo
description The present disclosure relates to single domain antibodies which binds to Clostridium difficile toxin B and their use in the treatment and prevention of Clostridium difficile infection. Further disclosed are nucleic acids and vectors encoding the single domain antibodies, host cells for expression of the single domain antibodies, methods of manufacture and compositions. La présente invention concerne des anticorps à domaine unique qui se lient à la toxine B du Clostridium difficile et leur utilisation dans le traitement et la prévention d'une infection à Clostridium difficile. L'invention concerne en outre des acides nucléiques et des vecteurs codant pour les anticorps à domaine unique, des cellules hôtes pour l'expression des anticorps à domaine unique, des procédés de fabrication et des compositions.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023099711A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023099711A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023099711A23</originalsourceid><addsrcrecordid>eNrjZPAK9vRz93FVcPH3dfT0U3D0C_F08nfxdA1WcPMPUggIcg1zBQr5-yn4uyk4-_gHhwR5uniG-iq4eLq5eTp7AnV6-rm5OoOU8DCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSS-HB_IwMjYwNLS3NDQ0cjY-JUAQAi6C52</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SINGLE DOMAIN ANTIBODIES FOR PREVENTION OF CLOSTRIDIUM DIFFICILE INFECTION</title><source>esp@cenet</source><creator>LAUSTSEN, Mads Aage ; THRANE, Sandra Wingaard ; LAUSTSEN, Andreas Hougaard ; RODRIGUEZ-RODRIGUEZ, Everardo</creator><creatorcontrib>LAUSTSEN, Mads Aage ; THRANE, Sandra Wingaard ; LAUSTSEN, Andreas Hougaard ; RODRIGUEZ-RODRIGUEZ, Everardo</creatorcontrib><description>The present disclosure relates to single domain antibodies which binds to Clostridium difficile toxin B and their use in the treatment and prevention of Clostridium difficile infection. Further disclosed are nucleic acids and vectors encoding the single domain antibodies, host cells for expression of the single domain antibodies, methods of manufacture and compositions. La présente invention concerne des anticorps à domaine unique qui se lient à la toxine B du Clostridium difficile et leur utilisation dans le traitement et la prévention d'une infection à Clostridium difficile. L'invention concerne en outre des acides nucléiques et des vecteurs codant pour les anticorps à domaine unique, des cellules hôtes pour l'expression des anticorps à domaine unique, des procédés de fabrication et des compositions.</description><language>eng ; fre</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; TESTING</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230608&amp;DB=EPODOC&amp;CC=WO&amp;NR=2023099711A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230608&amp;DB=EPODOC&amp;CC=WO&amp;NR=2023099711A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LAUSTSEN, Mads Aage</creatorcontrib><creatorcontrib>THRANE, Sandra Wingaard</creatorcontrib><creatorcontrib>LAUSTSEN, Andreas Hougaard</creatorcontrib><creatorcontrib>RODRIGUEZ-RODRIGUEZ, Everardo</creatorcontrib><title>SINGLE DOMAIN ANTIBODIES FOR PREVENTION OF CLOSTRIDIUM DIFFICILE INFECTION</title><description>The present disclosure relates to single domain antibodies which binds to Clostridium difficile toxin B and their use in the treatment and prevention of Clostridium difficile infection. Further disclosed are nucleic acids and vectors encoding the single domain antibodies, host cells for expression of the single domain antibodies, methods of manufacture and compositions. La présente invention concerne des anticorps à domaine unique qui se lient à la toxine B du Clostridium difficile et leur utilisation dans le traitement et la prévention d'une infection à Clostridium difficile. L'invention concerne en outre des acides nucléiques et des vecteurs codant pour les anticorps à domaine unique, des cellules hôtes pour l'expression des anticorps à domaine unique, des procédés de fabrication et des compositions.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPAK9vRz93FVcPH3dfT0U3D0C_F08nfxdA1WcPMPUggIcg1zBQr5-yn4uyk4-_gHhwR5uniG-iq4eLq5eTp7AnV6-rm5OoOU8DCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSS-HB_IwMjYwNLS3NDQ0cjY-JUAQAi6C52</recordid><startdate>20230608</startdate><enddate>20230608</enddate><creator>LAUSTSEN, Mads Aage</creator><creator>THRANE, Sandra Wingaard</creator><creator>LAUSTSEN, Andreas Hougaard</creator><creator>RODRIGUEZ-RODRIGUEZ, Everardo</creator><scope>EVB</scope></search><sort><creationdate>20230608</creationdate><title>SINGLE DOMAIN ANTIBODIES FOR PREVENTION OF CLOSTRIDIUM DIFFICILE INFECTION</title><author>LAUSTSEN, Mads Aage ; THRANE, Sandra Wingaard ; LAUSTSEN, Andreas Hougaard ; RODRIGUEZ-RODRIGUEZ, Everardo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023099711A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>LAUSTSEN, Mads Aage</creatorcontrib><creatorcontrib>THRANE, Sandra Wingaard</creatorcontrib><creatorcontrib>LAUSTSEN, Andreas Hougaard</creatorcontrib><creatorcontrib>RODRIGUEZ-RODRIGUEZ, Everardo</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LAUSTSEN, Mads Aage</au><au>THRANE, Sandra Wingaard</au><au>LAUSTSEN, Andreas Hougaard</au><au>RODRIGUEZ-RODRIGUEZ, Everardo</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SINGLE DOMAIN ANTIBODIES FOR PREVENTION OF CLOSTRIDIUM DIFFICILE INFECTION</title><date>2023-06-08</date><risdate>2023</risdate><abstract>The present disclosure relates to single domain antibodies which binds to Clostridium difficile toxin B and their use in the treatment and prevention of Clostridium difficile infection. Further disclosed are nucleic acids and vectors encoding the single domain antibodies, host cells for expression of the single domain antibodies, methods of manufacture and compositions. La présente invention concerne des anticorps à domaine unique qui se lient à la toxine B du Clostridium difficile et leur utilisation dans le traitement et la prévention d'une infection à Clostridium difficile. L'invention concerne en outre des acides nucléiques et des vecteurs codant pour les anticorps à domaine unique, des cellules hôtes pour l'expression des anticorps à domaine unique, des procédés de fabrication et des compositions.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2023099711A2
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
title SINGLE DOMAIN ANTIBODIES FOR PREVENTION OF CLOSTRIDIUM DIFFICILE INFECTION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T21%3A13%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LAUSTSEN,%20Mads%20Aage&rft.date=2023-06-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023099711A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true